Regulation of CAR T cell-mediated cytokine release syndrome-like toxicity using low molecular weight adapters
Chimeric antigen receptor (CAR) T cell anti-cancer therapies might result in toxic side effects. Here the authors present a strategy based on the modulation of CAR T cells via administration of a bispecific adapter that target them to cancer cells, resulting in diminished CAR-T cells toxicity and en...
Main Authors: | Yong Gu Lee, Haiyan Chu, Yingjuan Lu, Christopher P. Leamon, Madduri Srinivasarao, Karson S. Putt, Philip S. Low |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2019-06-01
|
Series: | Nature Communications |
Online Access: | https://doi.org/10.1038/s41467-019-10565-7 |
Similar Items
-
Design of a Near Infrared Fluorescent Ureter Imaging Agent for Prevention of Ureter Damage during Abdominal Surgeries
by: Sakkarapalayam M. Mahalingam, et al.
Published: (2021-06-01) -
Sensitive manipulation of CAR T cell activity using a chimeric endocytosing receptor
by: Boning Zhang, et al.
Published: (2020-07-01) -
Grading of cytokine release syndrome associated with the CAR T cell therapy tisagenlecleucel
by: David Porter, et al.
Published: (2018-03-01) -
Biomarkers of cytokine release syndrome and neurotoxicity related to CAR-T cell therapy
by: Zhenguang Wang, et al.
Published: (2018-01-01) -
A high-throughput microtiter plate based method for the determination of peracetic acid and hydrogen peroxide.
by: Karson S Putt, et al.
Published: (2013-01-01)